Metraipolis › archive › dc_2af64e8f7ee5

The Effects of Inclisiran on the Subclinical Prothrombotic and Platelet Activation Markers in Patients at High Cardiovascular Risk — Europe PMC PMID:41002634

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41002634
DOI
10.3390/jcdd12090355
License (as archived)
solo-consultazione
Archived
2026-11-09T22:32:27.474Z
SHA-256 of the archived text
9fe2e69c85b6b44ae97af6e68a617c9c20e59914bd5404ff2b5241c45c4725c5
Stable URL of this page
https://metraipolis.com/documento/dc_2af64e8f7ee5

How to cite

The Effects of Inclisiran on the Subclinical Prothrombotic and Platelet Activation Markers in Patients at High Cardiovascular Risk — Europe PMC PMID:41002634 — Europe PMC (en), https://europepmc.org/article/MED/41002634 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2af64e8f7ee5 (Metraipolis archive dc_2af64e8f7ee5, sha256 9fe2e69c85b6b44ae97af6e68a617c9c20e59914bd5404ff2b5241c45c4725c5)
BibTeX
@misc{dc2af64e8f7ee5,
  title = {The Effects of Inclisiran on the Subclinical Prothrombotic and Platelet Activation Markers in Patients at High Cardiovascular Risk — Europe PMC PMID:41002634},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41002634},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2af64e8f7ee5; sha256 9fe2e69c85b6b44ae97af6e68a617c9c20e59914bd5404ff2b5241c45c4725c5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41002634. Agents can read the archived copy with the MCP tool read_document.